ACTA1 and pancreatic ductal adenocarcinoma: αSMA-depleted CAFs, which express meflin, a glycosylphosphatidylinositol-anchored extracellular protein recognized as a marker for undifferentiated MSCs, suppress tumor progression in pancreatic ductal carcinoma cells [496].